METROPRESS XL 5 TABLET

Product Description

METROPRESS XL 5 TABLET Extended-Release Prazosin 5mg for Hypertension & BPH Management

METROPRESS XL 5 TABLET is a high-strength, extended-release formulation containing Prazosin Hydrochloride 5mg, a trusted alpha-1 adrenergic blocker. It is widely prescribed for the treatment of high blood pressure and benign prostatic hyperplasia (BPH) symptoms. The extended-release profile ensures steady therapeutic action over 24 hours, promoting better compliance and consistent symptom control.

Key Benefits:

• Effectively controls high blood pressure, reducing the risk of heart attack and stroke

• Relieves urinary symptoms associated with BPH by relaxing smooth muscle in the prostate and bladder neck

• Extended-release action ensures sustained efficacy with once-daily dosing

• Improves sleep quality by reducing nocturnal blood pressure surges

• Well-suited for long-term cardiovascular and urological care

Recommended Usage:
Ideal for patients with moderate to severe hypertension, resistant hypertension, and lower urinary tract symptoms due to BPH. Frequently prescribed by general physicians, cardiologists, and urologists.

Why Choose METROPRESS XL 5 TABLET?
Trusted for its therapeutic consistency and safety, METROPRESS XL 5 is a top choice for pharma wholesalers, hospitals, and bulk buyers seeking a dependable solution for dual cardiovascular and prostate health support.

Enhance your cardiovascular and urology product portfolio with METROPRESS XL 5 TABLET a clinically proven solution for modern hypertension and BPH management. Connect with us today for bulk orders and B2B distribution.